The approval comes under the National Priority Voucher Program, joining Augmentin XR as one of the few approvals from the voucher program as of February 27, 2026. Hernexeos was granted a national ...
The approval was based on a cohort of treatment-naïve patients in the Beamion LUNG-1 trial who had unresectable or metastatic, non-squamous NSCLC with HER2 tyrosine kinase domain mutations.
Erasca (NASDAQ:ERAS) executives outlined the company’s strategy to target RAS-driven cancers and previewed upcoming clinical ...
One woman shares her story of hope living with a rare and aggressive brain cancer. Jennifer's* story begins in a small town ...
The accelerated approval for patients with HER2 (ERBB2)-mutated disease follows an approval last August for use after prior ...
The US Food and Drug Administration (FDA) has granted accelerated approval to Hernexeos (zongertinib), from German family ...
Beam Therapeutics Inc. buy thesis: base-editing gene therapy leaders, risto-cel & BEAM-302 catalysts, strong cash runway.
Angelo Muro is a little tired. Working 80-hour weeks non-stop for more than a month and schlepping around dozens of 250-plus pound relics from yesteryear will do that to a person.
Hollywood’s elite are sounding the alarm as Seedance 2.0 proves AI can generate cinematic blockbusters from a single prompt. Is this the democratisation of film, or a death knell for human creativity?
If these Omega-level mutants make their way into the upcoming Avengers: Doomsday, the Doctor Doom will have no chance at ...
Deciding what to do about Elpis at the end of RE Requiem is a huge moment (NOTE: spoilers inside!) When you purchase through ...